June 10, 2021 -- Strateos announced it closed on $56 million in financing to continue to drive innovations on its SmartLab Platform.
Strateos develops remote-access laboratories and lab control software for life science research. Its SmartLab Platform integrates data generation and artificial intelligence automation to accelerate pharmaceutical and synthetic biology research and development.
The financing was led by DCVC and Lux Capital with participation from new investors, including Eli Lilly, Ally Bridge Group, Black Diamond Ventures, Mack & Co., and Castor Ventures, Strateos said.